Position in IONS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$22,515,188
+$4,625,897 QoQ
Shares Held
283,960
+19.2% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#79
of 510 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Derivatives in IONS
reported options exposure · as of Dec 31, 2021CallValue
$213,010
CallShares
7,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $137,698,050 across 19 Biotechnology names. IONS ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,108 | $102,876,756 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
This page
|
283,960 | $22,515,188 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
4,259,511 | $4,898,437 | |
| 4 | GMAB |
Genmab A/S
|
42,544 | $1,168,683 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
72,370 | $977,718 | |
| 6 | ARGX |
Argenx SE
|
929 | $861,898 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
3,190 | $768,694 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
19,500 | $651,105 |
All Filings in IONS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,515,188 | 283,960 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $17,889,291 | 238,238 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $17,237,831 | 217,897 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,092,871 | 62,563 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,561,946 | 64,843 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,701,376 | 56,393 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,193,390 | 62,740 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,028,455 | 75,598 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,845,113 | 80,678 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,638,278 | 83,928 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,367,333 | 86,328 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $3,940,740 | 86,877 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $3,603,131 | 87,817 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,881,251 | 80,617 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,044,904 | 80,617 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,753,490 | 84,863 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $3,084,432 | 83,318 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $3,106,285 | 83,863 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $213,010 | 7,000 | Call | Sole | 2022-02-10 | |
| 2021-12-31 | $2,576,295 | 84,663 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,102,042 | 122,303 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,665,654 | 116,963 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $5,608,220 | 124,738 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,905,682 | 122,138 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $5,814,428 | 122,538 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $7,462,920 | 126,576 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $6,469,133 | 136,826 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||